Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

12.04

-0.45 (-3.60%)

Jun 12, 2025, 4:00 PM - Market closed

Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	1,609	2,208	777	293	1,012	-	Upgrade
Market Cap Growth	68.97%	184.18%	165.01%	-71.03%	-	-	Upgrade
Enterprise Value	1,442	1,775	579	-83	433	-	Upgrade
Last Close Price	12.04	16.75	7.96	3.10	11.26	-	Upgrade
PS Ratio	98.54	-	113.40	-	-	-	Upgrade
PB Ratio	4.16	5.50	3.29	0.87	2.06	-	Upgrade
P/TBV Ratio	4.17	5.50	3.29	0.87	2.06	-	Upgrade
EV/Sales Ratio	96.15	-	84.53	-	-	-	Upgrade
Debt / Equity Ratio	0.31	0.29	0.36	0.21	0.15	1.82	Upgrade
Asset Turnover	0.04	-	0.02	-	-	-	Upgrade
Quick Ratio	13.93	9.10	7.51	10.97	24.84	1.18	Upgrade
Current Ratio	14.37	9.25	8.00	11.42	25.52	1.30	Upgrade
Return on Equity (ROE)	-74.44%	-73.93%	-52.79%	-52.24%	-154.41%	-	Upgrade
Return on Assets (ROA)	-28.58%	-26.82%	-26.61%	-24.48%	-27.16%	-	Upgrade
Return on Capital (ROIC)	-30.38%	-29.91%	-29.46%	-27.01%	-30.24%	-	Upgrade
Earnings Yield	-13.91%	-10.67%	-19.44%	-73.73%	-37.73%	-	Upgrade
FCF Yield	-10.07%	-6.43%	-20.65%	-68.77%	-13.47%	-	Upgrade
Buyback Yield / Dilution	-26.02%	-19.02%	-2.97%	-24.26%	-401.11%	-	Upgrade

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q